A potentiometric titration method for the crystallization of drug-like organic molecules

被引:2
|
作者
Du-Cuny, Lei
Huwyler, Joerg
Fischer, Holger
Kansy, Manfred [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Discovery Chem Mol Properties & Struct Property C, CH-4070 Basel, Switzerland
[2] Univ Appl Sci NW Switzerland, Inst Pharma Technol, CH-4132 Muttenz, Switzerland
关键词
crystal; crystallization; solubility; potentiometric titration;
D O I
10.1016/j.ijpharm.2007.05.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is generally accepted, that crystalline solids representing a low energy polymorph should be selected for development of oral dosage forms. As a consequence, efficient and robust procedures are needed at an early stage during drug discovery to prepare crystals from drug-like organic molecules. In contrast to the use of supersaturated solutions, we present a potentiometric crystallization procedure where saturated solutions are prepared in a controlled manner by pH-titration. Crystallization is carried out under defined conditions using the sample concentration and experimental pK(a) values as input parameters. Crystals of high quality were obtained for I I drugs selected to demonstrate the efficiency and applicability of the new method. Technical improvements are suggested to overcome practical limitations and to enhance the possibility of obtaining crystals from molecules in their uncharged form. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [41] Computer-based de novo design of drug-like molecules
    Schneider, G
    Fechner, U
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (08) : 649 - 663
  • [42] Assessment of TRPM7 functions by drug-like small molecules
    Chubanov, Vladimir
    Ferioli, Silvia
    Gudermann, Thomas
    CELL CALCIUM, 2017, 67 : 166 - 173
  • [43] QSPR prediction of aqueous solubility of drug-like organic compounds
    Ghasemi, Jahanbakhsh
    Saaidpour, Saadi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (04) : 669 - 674
  • [44] Drug-like index: A new approach to measure drug-like compounds and their diversity
    Xu, J
    Stevenson, J
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (05): : 1177 - 1187
  • [45] Improving the odds in discriminating "Drug-like" from "Non Drug-like" compounds
    Frimurer, TM
    Bywater, R
    Nærum, L
    Lauritsen, LN
    Brunak, S
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2000, 40 (06): : 1315 - 1324
  • [46] Aqueous and cosolvent solubility data for drug-like organic compounds
    Rytting, E
    Lentz, KA
    Chen, XQ
    Qian, F
    Venkatesh, S
    AAPS JOURNAL, 2005, 7 (01): : E78 - E105
  • [47] Modeling epoxidation of drug-like molecules with a deep machine learning network
    Swamidass, S. Joshua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [48] Computer-based de novo design of drug-like molecules
    Gisbert Schneider
    Uli Fechner
    Nature Reviews Drug Discovery, 2005, 4 : 649 - 663
  • [49] Late-Stage Functionalization of Drug-Like Molecules Using Diversinates
    Kuttruff, Christian A.
    Haile, Margit
    Kraml, Johannes
    Tautermann, Christofer S.
    CHEMMEDCHEM, 2018, 13 (10) : 983 - 987
  • [50] Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network
    Hughes, Tyler B.
    Miller, Grover P.
    Swamidass, S. Joshua
    ACS CENTRAL SCIENCE, 2015, 1 (04) : 168 - 180